# LORAZEPAM

NDC: 61919-062
Generic name: LORAZEPAM
Labeler / Manufacturer: DIRECT RX
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20170210

FDA application: ANDA078203

## Active ingredients

- LORAZEPAM: .5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"61919-062"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=61919-062
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4832f02d-289c-2fe6-e054-00144ff8d46c